If a Saphenous Graft Is Available, Treat CLTI Surgically
Surgery beats endovascular treatment for limb threatening ischemia when saphenous grafts are an option, according to the BEST-CLI trial.
Source: medscape.com
Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Surgery beats endovascular treatment for limb threatening ischemia when saphenous grafts are an option, according to the BEST-CLI trial.
The company's top-selling drug brought in the most revenue last quarter and was also its fastest-growing product.
Biobanking Market Projected To Reach Around US$ 88 Bn by 2032: Fact.MR Analysis
Biobanking Market Projected To Reach Around US$ 88 Bn by 2032: Fact.MR Analysis
Great companies grow their top and bottom lines, but they also plug into trends rooted in cultural change, consumer convenience, and practicality.